Clinical Trial Update: Cilostazol and Aspirin in Stroke and TIA [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial assessing the combination of cilostazol and aspirin in patients with ischemic stroke or transient ischemic attack has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke
• Transient Ischemic Attack

Drugs mentioned

• Aspirin (Aspirin)
• Cilostazol (Cilostazol)

Snippet

Sponsor: Incheon St.Mary's Hospital | Conditions: Ischemic Stroke, TIA | Phase 4 | Status: COMPLETED